Welcome to LookChem.com Sign In|Join Free
  • or
(R)-1-methylpyrrolidine-3-amine hydrochloride, also known as (R)-1-MPA·HCl, is a chiral amine compound that serves as a crucial intermediate in the pharmaceutical and organic synthesis industries. It is the hydrochloride salt form of (R)-1-methylpyrrolidine-3-amine, which is characterized by its unique molecular structure and chiral properties. These features make it a valuable component in the development of chiral ligands, catalysts, and potential therapeutic agents. The hydrochloride form enhances its stability and ease of handling in laboratory settings.

346690-76-4

Post Buying Request

346690-76-4 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

346690-76-4 Usage

Uses

Used in Pharmaceutical Research and Drug Development:
(R)-1-methylpyrrolidine-3-amine hydrochloride is used as an intermediate in the synthesis of various pharmaceuticals and organic compounds. Its role in creating chiral molecules is essential for the development of new drugs with improved efficacy and selectivity.
Used in the Synthesis of Chiral Ligands and Catalysts:
(R)-1-methylpyrrolidine-3-amine hydrochloride is utilized as a building block for the creation of chiral ligands and catalysts. These are vital in asymmetric synthesis, a technique that allows for the production of enantiomerically pure compounds, which are often necessary for the desired biological activity of drugs.
Used in the Development of Therapeutic Agents:
(R)-1-methylpyrrolidine-3-amine hydrochloride is used as a key component in the development of potential therapeutic agents. Its chiral nature allows for the creation of drugs that can target specific biological pathways, leading to more effective treatments with fewer side effects.
Used in Medicinal Chemistry:
In the field of medicinal chemistry, (R)-1-methylpyrrolidine-3-amine hydrochloride is used for its unique molecular structure and chiral properties. It aids in the design and synthesis of novel compounds with potential therapeutic applications, contributing to the advancement of drug discovery and development.
Used in Organic Synthesis:
(R)-1-methylpyrrolidine-3-amine hydrochloride is also used in organic synthesis, where it can be employed to create a variety of chiral molecules with specific properties. These molecules can be used in various applications, including the development of new materials, agrochemicals, and other specialty chemicals.

Check Digit Verification of cas no

The CAS Registry Mumber 346690-76-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,4,6,6,9 and 0 respectively; the second part has 2 digits, 7 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 346690-76:
(8*3)+(7*4)+(6*6)+(5*6)+(4*9)+(3*0)+(2*7)+(1*6)=174
174 % 10 = 4
So 346690-76-4 is a valid CAS Registry Number.

346690-76-4Relevant academic research and scientific papers

FUSED RING COMPOUND FOR USE AS MINERALOCORTICOID RECEPTOR ANTAGONIST

-

Paragraph 0151, (2013/07/19)

The present invention belongs to the technical field of medicine, relating in particular to: a fused ring compound as represented by Formula (I) for use as a mineralocorticoid receptor antagonist, a pharmaceutically acceptable salt thereof, and an isomer thereof; a preparation method for these compounds; a pharmaceutical preparation containing these compounds; and an application of these compounds, the pharmaceutically acceptable salt thereof, or the isomers thereof in the preparation of medicants for the treatment and/or prevention of kidney injury, cardiovascular diseases such as hypertension, and/or endocrine disease. The definitions of X, Y1, Y2, Y3, R1, R2a,R2b , R3a , R3b, R4, Cy and n are as presented in the description.

Fused Ring Compound For Use As Mineralocorticoid Receptor Antagonist

-

Paragraph 0222; 0224, (2013/11/06)

The present invention belongs to the technical field of medicine, relating in particular to: a fused ring compound as represented by Formula (I) for use as a mineralocorticoid receptor antagonist, a pharmaceutically acceptable salt thereof, and an isomer thereof; a preparation method for these compounds; a pharmaceutical preparation containing these compounds; and an application of these compounds, the pharmaceutically acceptable salt thereof, or the isomers thereof in the preparation of medicants for the treatment and/or prevention of kidney injury, cardiovascular diseases such as hypertension, and/or endocrine disease. The definitions of X, Y1, Y2, Y3, R1, R2a, R2b, R3a, R3b, R4, Cy and n are as presented in the description.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 346690-76-4